CLRB · Cellectar Biosciences, Inc.
$2.40
-0.07 (-2.83%)
At close · Jul 24
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These uncertainties raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$19.26M
Shares
7.99M
Cellectar Biosciences, Inc. Earnings Call Transcripts
Every quarterly earnings call for Cellectar Biosciences, Inc. (CLRB) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Annual General Meeting
Investor event
2026-07-07
2026 Annual Meeting of Stockholders
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-14
Cellectar Biosciences, Inc. Q1 FY2026 Earnings Call
Confident tone
Waldenstrom Macroglobulinemia unmet need
Phase III confirmatory trial design
Iopofosine I-131 CLOVER WaM Phase IIb data
Diluted EPS
$-1.33
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-04
Cellectar Biosciences, Inc. Q4 FY2025 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Conference
Investor event
2026-01-13
44th Annual JP Morgan Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q3
2025-11-13
Cellectar Biosciences, Inc. Q3 FY2025 Earnings Call
Diluted EPS
$-1.41
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
Cellectar Biosciences, Inc. Q2 FY2025 Earnings Call
Diluted EPS
$-3.39
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
Cellectar Biosciences, Inc. Q1 FY2025 Earnings Call
Diluted EPS
$-4.30
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-13
Cellectar Biosciences, Inc. Q4 FY2024 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-18
Cellectar Biosciences, Inc. Q3 FY2024 Earnings Call
Diluted EPS
$-12.13
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-23
Cellectar Biosciences, Inc. Q2 FY2024 Earnings Call
Positive tone
CLOVER WaM pivotal study data
NDA filing and FDA review
Manufacturing and CMC
Diluted EPS
$-5.43
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Cellectar Biosciences, Inc. Q1 FY2024 Earnings Call
Diluted EPS
$-27.30
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-27
Cellectar Biosciences, Inc. Q4 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Cellectar Biosciences, Inc. Q3 FY2023 Earnings Call
Diluted EPS
$-46.50
Audio
Transcript
Slides
8-K10-Q
Showing 1–13 of 13 earnings calls